Revance Therapeutics, Inc.
USD3.65
+0.00 (+0.00%)
CEO
Mark J. Foley
IPO Date
2014-02-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$3.65
Prev. Close
$3.65
Day Low
$3.65
Day High
$3.65
52W Low
$2.30
52W High
$7.56
Market Cap
$0.38B
| 15,000 |
| $0.00 |
| 6 Feb 2025 | Hollander David | CMO & Global Therapeutics Lead | U-Tender | Disposed | 9,733 | $3.65 |
| 6 Feb 2025 | Hollander David | CMO & Global Therapeutics Lead | D-Return | Disposed | 95,212 | $0.00 |
| 6 Feb 2025 | Coric Vlad | director | U-Tender | Disposed | 5,784 | $3.65 |
| 6 Feb 2025 | Coric Vlad | director | D-Return | Disposed | 15,000 | $0.00 |
| 6 Feb 2025 | Beraud Jill | director | U-Tender | Disposed | 28,606 | $3.65 |
| 6 Feb 2025 | Beraud Jill | director | D-Return | Disposed | 15,000 | $0.00 |
| 6 Feb 2025 | Moxie Dwight | CLO & GC | U-Tender | Disposed | 47,815 | $3.65 |
| 6 Feb 2025 | Moxie Dwight | CLO & GC | A-Award | Acquired | 18,125 | $0.00 |